| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2776825 | Journal of Oral Biosciences | 2014 | 4 Pages |
BackgroundIn recent years, the role of the sympathetic nervous system in bone metabolism has been revealed. Many studies have suggested that bone loss can be induced by continuously high sympathetic tone resulting from up-regulation of osteoclastogenesis and osteoclastic activity via β2-adrenergic receptors. Although the expression of α-adrenergic receptors in osteoblasts and osteoclasts has been demonstrated, the physiological roles of these receptors in bone metabolism remain unclear. In the present review, we provide an account of the role of α1-adrenergic receptors in bone metabolism.ConclusionExperimental studies in osteoblasts suggest that not only the suppression of β2-adrenergic receptors but also the activation of α1-adrenergic receptors could lead to a treatment for osteoporosis. Studying the signaling pathway will help elucidate the mechanism underlying the regulation of bone metabolism via the α1-adrenergic receptor and also facilitate the development of a novel therapeutic strategy for osteoporosis.
